Kidney Disease Is Rising – Understanding Your Risk
Kidney disease is often thought of as a late-stage complication of other illnesses, something that appears after years of diabetes or long-standing high blood pressure. However, recent data suggests a more concerning reality. Chronic kidney disease is rising steadily, and many people are developing kidney damage earlier than expected, often without realising it.
Why kidney disease is becoming more common
A major international study published in The Lancet, has revealed a sharp increase in chronic kidney disease worldwide, driven largely by metabolic conditions such as Type 2 diabetes, obesity, and hypertension. These conditions place sustained strain on the kidneys, gradually impairing their ability to filter waste, regulate fluids, and maintain electrolyte balance.
The kidneys are highly sensitive organs. Persistent high blood sugar damages the tiny blood vessels responsible for filtration. Elevated blood pressure increases pressure within the kidney’s delicate structures. Over time, this combination leads to scarring and loss of function.
What’s often overlooked is that kidney disease doesn’t suddenly appear once diabetes or hypertension is diagnosed. It develops slowly, often during years of insulin resistance, inflammation, and metabolic imbalance that precede formal diagnoses. This long lead-in period represents a missed opportunity for prevention.
Metabolic dysfunction and hidden kidney risk
Metabolic dysfunction plays a central role in rising kidney disease rates. Insulin resistance, central obesity, and chronic low-grade inflammation all contribute to kidney stress. Even people with borderline blood sugar or blood pressure readings may already be placing strain on their kidneys without knowing it.
Standard screening often focuses on later-stage markers such as reduced kidney filtration rate. While these tests are essential, they don’t always capture early dysfunction. In the early stages, there are no clear symptoms and by the time it is picked up on a routine test, the damage may already be advanced.
This is why early metabolic screening matters. Identifying insulin resistance, inflammation, and vascular stress early allows intervention before kidney damage becomes irreversible.
How environmental exposure increases the risk
As well as metabolic health, environmental factors are increasingly recognised as contributors to kidney disease. A large review has linked long-term exposure to air pollution and heavy metals with increased risk of chronic kidney disease.
Pollutants such as fine particulate matter, lead, and cadmium can accumulate in the body over time, placing additional stress on the kidneys. These exposures often act alongside metabolic risk factors, compounding damage rather than acting alone.
For people living in urban environments or with occupational exposure, this is another reason to take kidney health seriously.
Why early screening makes such a difference
Kidney disease is far easier to slow, stabilise, or even prevent when identified early. Simple blood and urine tests can detect early changes long before symptoms appear, but only if they’re used proactively.
Early screening helps you to make more informed decisions around nutrition, blood sugar control, blood pressure management, hydration, and medication use. It also provides the opportunity to reduce exposure to environmental stressors where possible.
For Dr Konrad Grosser, kidney health is never assessed in isolation. As an interventional cardiologist with additional training in functional and metabolic medicine, he looks at kidney function alongside cardiovascular health, metabolic markers, inflammation, and hormonal balance.
His assessments often include early markers of kidney strain, alongside metabolic testing such as fasting insulin, inflammatory indicators, and measures of vascular health. Biological age testing can provide additional context around vascular ageing when interpreted alongside established clinical markers.
This integrated approach allows prevention strategies to be personalised. For some, that may mean improving insulin sensitivity and reducing inflammation. For others, it may involve addressing blood pressure variability, reviewing medications, or supporting renal and hepatic clearance mechanisms.
A consultation with Dr Grosser offers the opportunity to assess kidney health as part of a wider, preventative strategy that protects long-term cardiovascular and metabolic health too.
